Co-delivery of paclitaxel and anti-VEGF siRNA by tripeptide lipid nanoparticle to enhance the anti-tumor activity for lung cancer therapy

The combination of chemotherapeutic drug paclitaxel (PTX) and VEGF siRNA could inhibit cancer development with synergistic efficacy. However, efficient and safe delivery systems with high encapsulation efficiency of PTX and a long-time release of drugs are urgently needed. In this study, novel nanop...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chuanmin, Zhao, Yinan, Zhang, Enxia, Jiang, Meilin, Zhi, Defu, Chen, Huiying, Cui, Shaohui, Zhen, Yuhong, Cui, Jingnan, Zhang, Shubiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594708/
https://www.ncbi.nlm.nih.gov/pubmed/33096948
http://dx.doi.org/10.1080/10717544.2020.1827085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594708/
https://www.ncbi.nlm.nih.gov/pubmed/33096948
http://dx.doi.org/10.1080/10717544.2020.1827085

Ejemplares similares